Showing results (1601-1610 of 1,800) with videos related to
Sort By:
Pageof 180
Nature Communications|March 5, 2015
Adiponectin receptor 1 conserves docosahexaenoic acid and promotes photoreceptor cell survivalDennis S Rice, Jorgelina M Calandria, William C Gordon, et al.Journal of Viral Hepatitis|March 31, 2016
Hepatitis C treatment failure is associated with increased risk of hepatocellular carcinomaMei Lu, Jia Li, Loralee B Rupp, et al.Journal of the American College of Cardiology|September 14, 1999
Acute and nine-month clinical outcomes after "suboptimal" coronary stenting: results from the STent Anti-thrombotic Regimen Study (STARS) registryD E Cutlip, M B Leon, K K Ho, et al.Blood|July 15, 2006
Synthetic anti-BR3 antibodies that mimic BAFF binding and target both human and murine B cellsChingwei V Lee, Sarah G Hymowitz, Heidi J Wallweber, et al.Digestive Diseases and Sciences|July 18, 2014
Comparative effectiveness research of chronic hepatitis B and C cohort study (CHeCS): improving data collection and cohort identificationMei Lu, Loralee B Rupp, Anne C Moorman, et al.Chemical Science|March 7, 2017
Design and engineering of water-soluble light-harvesting protein maquettesGoutham Kodali, Joshua A Mancini, Lee A Solomon, et al.Chest|September 18, 2015
Congenital Central Hypoventilation Syndrome: Neurocognition Already Reduced in Preschool-Aged ChildrenAaron J Charnay, Jeanne E Antisdel-Lomaglio, Frank A Zelko, et al.Advances in Therapy|May 22, 2021
Safety of Patients with Hepatitis C Virus Treated with Glecaprevir/Pibrentasvir from Clinical Trials and Real-World CohortsXavier Forns, Jordan J Feld, Douglas E Dylla, et al.Hepatology (Baltimore, Md.)|May 13, 2015
Safety and tolerability of ledipasvir/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: Analysis of phase III ION trialsSaleh A Alqahtani, Nezam Afdhal, Stefan Zeuzem, et al.Plos One|July 8, 2022
Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysisPeter J Godolphin, David J Fisher, Lindsay R Berry, et al.Pageof 180